CTI BIOPHARMA CORP's ticker is CTIC and the CUSIP is 12648L601. A total of 69 filers reported holding CTI BIOPHARMA CORP in Q1 2019. The put-call ratio across all filers is 1.28 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $14,744,851 | +164.8% | 3,510,679 | +279.0% | 0.00% | +100.0% |
| Q4 2022 | $5,567,442 | +33.8% | 926,363 | +29.5% | 0.00% | – |
| Q3 2022 | $4,162,000 | +171.0% | 715,063 | +177.9% | 0.00% | – |
| Q2 2022 | $1,536,000 | +5385.7% | 257,283 | +4260.7% | 0.00% | – |
| Q1 2022 | $28,000 | +833.3% | 5,900 | +354.5% | 0.00% | – |
| Q4 2021 | $3,000 | -95.9% | 1,298 | -94.8% | 0.00% | – |
| Q3 2021 | $74,000 | – | 25,111 | +75993.9% | 0.00% | – |
| Q2 2021 | $0 | – | 33 | -31.2% | 0.00% | – |
| Q2 2020 | $0 | -100.0% | 48 | -99.1% | 0.00% | – |
| Q3 2019 | $4,000 | -97.8% | 5,341 | -97.5% | 0.00% | – |
| Q2 2019 | $186,000 | +2557.1% | 216,316 | +2616.5% | 0.00% | – |
| Q1 2019 | $7,000 | -53.3% | 7,963 | -62.0% | 0.00% | – |
| Q4 2018 | $15,000 | -40.0% | 20,967 | +82.9% | 0.00% | – |
| Q3 2018 | $25,000 | -21.9% | 11,462 | +77.1% | 0.00% | – |
| Q2 2018 | $32,000 | -46.7% | 6,472 | -57.8% | 0.00% | – |
| Q1 2018 | $60,000 | – | 15,329 | +170222.2% | 0.00% | – |
| Q4 2017 | $0 | -100.0% | 9 | -96.4% | 0.00% | – |
| Q3 2017 | $1,000 | 0.0% | 247 | +8.8% | 0.00% | – |
| Q2 2017 | $1,000 | – | 227 | +1094.7% | 0.00% | – |
| Q1 2017 | $0 | – | 19 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 3,904,400 | $3,355,000 | 2.31% |
| BVF INC/IL | 6,929,690 | $5,955,000 | 0.65% |
| CAXTON CORP | 324,452 | $279,000 | 0.32% |
| NEA Management Company, LLC | 3,750,000 | $3,222,000 | 0.23% |
| Orbimed Advisors | 5,000,000 | $4,297,000 | 0.07% |
| Fosun International Ltd | 459,274 | $390,000 | 0.03% |
| Paloma Partners Management Co | 229,800 | $197,000 | 0.00% |
| OXFORD ASSET MANAGEMENT LLP | 127,602 | $110,000 | 0.00% |
| LMR Partners LLP | 54,931 | $47,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 17,495 | $15,000 | 0.00% |